The global CT And MRI Contrast Agents Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Product (Gadolinium-based Contrast Media, Iodinated Contrast Media), By Modality (Magnetic Resonance Imaging, X-ray/Computed Tomography), By Application (Cardiovascular Disorders, Neurological Disorders, Gastrointestinal Disorders, Cancer, Nephrological Disorders, Musculoskeletal Disorders, Others), By Route of Administration (Intravenous, Oral Route, Rectal Route), By End-User (Hospitals, Diagnostic Imaging Centers, Others).
The CT and MRI Contrast Agents Market is growing steadily, fueled by the rising prevalence of chronic diseases, such as cardiovascular disorders, cancer, and neurological conditions, which require diagnostic imaging. Contrast agents enhance the visibility of internal structures by improving image clarity, enabling more accurate diagnosis. Iodinated contrast agents are widely used in CT scans, while gadolinium-based agents are dominant in MRI procedures. The increasing adoption of minimally invasive diagnostic procedures and the rising geriatric population are driving market demand. However, concerns over gadolinium deposition and nephrotoxicity risks pose regulatory and safety challenges. Innovations in macrocyclic agents, which offer better safety profiles, and the development of novel nanoparticle-based contrast agents are enhancing market potential. As diagnostic imaging volumes increase globally, particularly in emerging economies, the CT and MRI contrast agents market is expected to witness robust growth.
The market report analyses the leading companies in the industry including Bayer, Bracco Diagnostics Inc, Fresenius Kabi USA LLC, GE HealthCare, Guerbet, and others.
The CT and MRI contrast agents market is witnessing a trend toward the development and adoption of gadolinium-free contrast agents due to safety concerns over gadolinium retention in the brain and body. With regulatory agencies and healthcare providers prioritizing patient safety, non-gadolinium-based agents, such as manganese and iron oxide nanoparticles, are gaining attention. This trend is driving innovation in safer, biodegradable contrast agents, addressing growing concerns regarding gadolinium deposition.
The rising number of diagnostic imaging procedures for chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, is a key driver for the CT and MRI contrast agents market. With the growing prevalence of these conditions, the demand for accurate and enhanced imaging is surging, boosting the use of contrast agents. Additionally, advancements in imaging technologies and the increasing adoption of MRI and CT scans in early disease detection are driving market growth.
An emerging opportunity in the CT and MRI contrast agents market lies in the integration of artificial intelligence (AI) with contrast-enhanced imaging. AI-powered image analysis is enhancing diagnostic accuracy and reducing scan times. The combination of AI and contrast-enhanced imaging offers improved detection of abnormalities, creating new growth avenues for contrast agent manufacturers partnering with AI firms. Additionally, the development of microbubble contrast agents for molecular imaging presents future growth potential.
China's CT and MRI contrast agents market is driven by the country's rising incidence of chronic diseases, particularly cancer and cardiovascular disorders, which necessitate frequent diagnostic imaging. The growing adoption of advanced imaging technologies in public and private hospitals is boosting demand for contrast agents. Additionally, the expansion of healthcare infrastructure in rural areas, driven by government initiatives, is increasing access to diagnostic procedures. The rising geriatric population, which is more prone to chronic conditions, is further fueling demand for contrast-enhanced imaging. The presence of local manufacturers offering cost-effective contrast agents is also promoting market growth.
India's CT and MRI contrast agents market is expanding due to the rising prevalence of chronic diseases, including cancer, neurological disorders, and cardiovascular conditions. The increasing accessibility of advanced diagnostic imaging in tier-2 and tier-3 cities, driven by expanding private healthcare networks, is boosting demand. Additionally, the growing medical tourism sector, offering cost-effective diagnostic procedures, is fueling the use of contrast agents. The rising adoption of MRI in neurological and musculoskeletal imaging, coupled with the increasing availability of high-end CT scanners, is further driving market growth.
The US CT and MRI contrast agents market is driven by the country's high volume of diagnostic imaging procedures and advanced healthcare infrastructure. The increasing incidence of cancer, neurological disorders, and cardiovascular diseases is fueling demand for contrast-enhanced CT and MRI scans. Additionally, the growing adoption of gadolinium-based contrast agents (GBCAs) in brain and spine imaging is boosting market growth. The presence of major pharmaceutical companies and continuous FDA approvals for new contrast agents are further expanding the market. The rising use of advanced imaging techniques in precision medicine is also contributing to increased demand.
Germany's CT and MRI contrast agents market is expanding due to the country's high healthcare standards and advanced diagnostic capabilities. The rising prevalence of chronic diseases, particularly cancer and cardiovascular conditions, is driving demand for contrast-enhanced imaging. Additionally, the increasing use of MRI for neurological and musculoskeletal diagnostics is boosting the adoption of gadolinium and iron oxide-based contrast agents. The country's focus on early disease detection and preventive healthcare is further promoting the use of contrast-enhanced imaging in routine diagnostics.
France's CT and MRI contrast agents market is driven by the country's growing demand for advanced diagnostic imaging in oncology, cardiology, and neurology. The rising use of MRI for brain and spine imaging, particularly in neurodegenerative disease diagnosis, is boosting demand for contrast agents. Additionally, the increasing adoption of low-osmolar iodinated contrast agents in CT imaging is fueling market growth. France's strong healthcare reimbursement policies and access to advanced imaging technologies are further promoting the widespread use of contrast-enhanced diagnostic procedures.
The Middle East CT and MRI contrast agents market is growing due to the region's expanding healthcare infrastructure and rising prevalence of chronic diseases. The increasing use of diagnostic imaging for cancer screening and cardiovascular disease management is driving demand for contrast agents. Additionally, the growing number of private healthcare facilities offering advanced MRI and CT procedures, particularly in the UAE and Saudi Arabia, is boosting market growth. The rising adoption of contrast-enhanced imaging in neurology and musculoskeletal diagnostics is further fueling demand. The region's increasing focus on medical tourism is also contributing to market expansion.
|
Parameter |
Details |
|
Market Size (2025) |
$7 Billion |
|
Market Size (2034) |
$13.2 Billion |
|
Market Growth Rate |
7.3% |
|
Segments |
By Product (Gadolinium-based Contrast Media, Iodinated Contrast Media), By Modality (Magnetic Resonance Imaging, X-ray/Computed Tomography), By Application (Cardiovascular Disorders, Neurological Disorders, Gastrointestinal Disorders, Cancer, Nephrological Disorders, Musculoskeletal Disorders, Others), By Route of Administration (Intravenous, Oral Route, Rectal Route), By End-User (Hospitals, Diagnostic Imaging Centers, Others) |
|
Study Period |
2019- 2024 and 2025-2034 |
|
Units |
Revenue (USD) |
|
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
|
Companies |
Bayer, Bracco Diagnostics Inc, Fresenius Kabi USA LLC, GE HealthCare, Guerbet |
|
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Product
Gadolinium-based Contrast Media
Iodinated Contrast Media
By Modality
Magnetic Resonance Imaging
X-ray/Computed Tomography
By Application
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Others
By Route of Administration
Intravenous
Oral Route
Rectal Route
By End-User
Hospitals
Diagnostic Imaging Centers
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Bayer
Bracco Diagnostics Inc
Fresenius Kabi USA LLC
GE HealthCare
Guerbet
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
- Market Segments
- Companies Profiled
Research Methodology
- Bottom-Up Method
- Top-Down Method
- Data Triangulation
Forecast Methodology
- Data Sources
- USDA Proprietary Databases
- External Sources
- Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global CT And MRI Contrast Agents Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- CT And MRI Contrast Agents Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical CT And MRI Contrast Agents Market Size by Segments, 2018- 2024
Key Statistics, 2024
CT And MRI Contrast Agents Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across CT And MRI Contrast Agents Types, 2018- 2024
CT And MRI Contrast Agents Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across CT And MRI Contrast Agents Applications, 2018- 2024
8. CT And MRI Contrast Agents Market Size Outlook by Segments, 2024- 2034
By Product
Gadolinium-based Contrast Media
Iodinated Contrast Media
By Modality
Magnetic Resonance Imaging
X-ray/Computed Tomography
By Application
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Others
By Route of Administration
Intravenous
Oral Route
Rectal Route
By End-User
Hospitals
Diagnostic Imaging Centers
Others
9. CT And MRI Contrast Agents Market Size Outlook by Region
North America
Key Market Dynamics
North America CT And MRI Contrast Agents Market Size Outlook by Type, USD Million, 2021-2034
North America CT And MRI Contrast Agents Market Size Outlook by Application, USD Million, 2021-2034
North America CT And MRI Contrast Agents Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America CT And MRI Contrast Agents Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe CT And MRI Contrast Agents Market Size Outlook by Type, USD Million, 2021-2034
Europe CT And MRI Contrast Agents Market Size Outlook by Application, USD Million, 2021-2034
Europe CT And MRI Contrast Agents Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe CT And MRI Contrast Agents Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific CT And MRI Contrast Agents Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific CT And MRI Contrast Agents Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific CT And MRI Contrast Agents Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific CT And MRI Contrast Agents Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America CT And MRI Contrast Agents Market Size Outlook by Type, USD Million, 2021-2034
South America CT And MRI Contrast Agents Market Size Outlook by Application, USD Million, 2021-2034
South America CT And MRI Contrast Agents Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America CT And MRI Contrast Agents Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa CT And MRI Contrast Agents Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa CT And MRI Contrast Agents Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa CT And MRI Contrast Agents Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa CT And MRI Contrast Agents Market Size Outlook by Country, USD Million, 2021-2034
10. United States CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
United States CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
United States CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
United States CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
11. Canada CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Canada CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Canada CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
12. Mexico CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Mexico CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Mexico CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
13. Germany CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Germany CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Germany CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
14. France CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
France CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
France CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
France CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
15. United Kingdom CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
United Kingdom CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
United Kingdom CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
16. Spain CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Spain CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Spain CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
17. Italy CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Italy CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Italy CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
18. Benelux CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Benelux CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Benelux CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
19. Nordic CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Nordic CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Nordic CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Rest of Europe CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Rest of Europe CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
21. China CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
China CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
China CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
China CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
22. India CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
India CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
India CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
India CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
23. Japan CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Japan CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Japan CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
24. South Korea CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
South Korea CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
South Korea CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
25. Australia CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Australia CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Australia CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
26. South East Asia CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
South East Asia CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
South East Asia CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
28. Brazil CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Brazil CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Brazil CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
29. Argentina CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Argentina CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Argentina CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
30. Rest of South America CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Rest of South America CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Rest of South America CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
United Arab Emirates CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
United Arab Emirates CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Saudi Arabia CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Saudi Arabia CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Rest of Middle East CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Rest of Middle East CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
34. South Africa CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
South Africa CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
South Africa CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa CT And MRI Contrast Agents Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa CT And MRI Contrast Agents Market Size Outlook by Type, 2021- 2034
Rest of Africa CT And MRI Contrast Agents Market Size Outlook by Application, 2021- 2034
Rest of Africa CT And MRI Contrast Agents Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
Bayer
Bracco Diagnostics Inc
Fresenius Kabi USA LLC
GE HealthCare
Guerbet
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Product
Gadolinium-based Contrast Media
Iodinated Contrast Media
By Modality
Magnetic Resonance Imaging
X-ray/Computed Tomography
By Application
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Others
By Route of Administration
Intravenous
Oral Route
Rectal Route
By End-User
Hospitals
Diagnostic Imaging Centers
Others
The Global CT And MRI Contrast Agents Market Size is estimated at $7 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 7.3% to reach $13.2 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bayer, Bracco Diagnostics Inc, Fresenius Kabi USA LLC, GE HealthCare, Guerbet
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume